Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 664

1.

Neutrophil CD40 enhances platelet-mediated inflammation.

Vanichakarn P, Blair P, Wu C, Freedman JE, Chakrabarti S.

Thromb Res. 2008;122(3):346-58. doi: 10.1016/j.thromres.2007.12.019. Epub 2008 Mar 4.

PMID:
18289643
2.

CD40 ligand influences platelet release of reactive oxygen intermediates.

Chakrabarti S, Varghese S, Vitseva O, Tanriverdi K, Freedman JE.

Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2428-34. Epub 2005 Sep 1.

3.

Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity.

Amirkhosravi A, Amaya M, Desai H, Francis JL.

Blood Coagul Fibrinolysis. 2002 Sep;13(6):505-12.

PMID:
12192302
4.

Soluble CD40 ligand stimulates CD40-dependent activation of the β2 integrin Mac-1 and protein kinase C zeda (PKCζ) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst.

Jin R, Yu S, Song Z, Zhu X, Wang C, Yan J, Wu F, Nanda A, Granger DN, Li G.

PLoS One. 2013 Jun 6;8(6):e64631. doi: 10.1371/journal.pone.0064631. Print 2013.

5.

CD40-40L signaling in vascular inflammation.

Chakrabarti S, Blair P, Freedman JE.

J Biol Chem. 2007 Jun 22;282(25):18307-17. Epub 2007 Apr 25.

6.

TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.

Danese S, Sans M, Scaldaferri F, Sgambato A, Rutella S, Cittadini A, Piqué JM, Panes J, Katz JA, Gasbarrini A, Fiocchi C.

J Immunol. 2006 Feb 15;176(4):2617-24.

7.

CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.

Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ.

Circ Res. 2003 May 16;92(9):1041-8. Epub 2003 Apr 3.

8.

Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species.

Bou Khzam L, Hachem A, Zaid Y, Boulahya R, Mourad W, Merhi Y.

Thromb Haemost. 2013 May;109(5):940-7. doi: 10.1160/TH12-09-0679. Epub 2013 Feb 21.

PMID:
23426185
9.

Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation with no effect of aspirin intake.

Giannini S, Falcinelli E, Bury L, Guglielmini G, Rossi R, Momi S, Gresele P.

Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2072-9. doi: 10.1152/ajpheart.00467.2010. Epub 2011 Mar 4.

PMID:
21378140
10.

CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.

Büchner K, Henn V, Gräfe M, de Boer OJ, Becker AE, Kroczek RA.

J Pathol. 2003 Oct;201(2):288-95.

PMID:
14517846
11.

Effects of alimentary lipemia and inflammation on platelet CD40-ligand.

Kälsch T, Elmas E, Nguyen XD, Kralev S, Leweling H, Klüter H, Dempfle CE, Borggrefe M.

Thromb Res. 2007;120(5):703-8. Epub 2007 Feb 6.

PMID:
17289125
12.

Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients.

Danese S, de la Motte C, Sturm A, Vogel JD, West GA, Strong SA, Katz JA, Fiocchi C.

Gastroenterology. 2003 May;124(5):1249-64.

PMID:
12730866
13.

Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.

Lee SP, Ataga KI, Orringer EP, Phillips DR, Parise LV.

Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1626-31. Epub 2006 Apr 6.

14.

Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification.

Danese S, de la Motte C, Reyes BM, Sans M, Levine AD, Fiocchi C.

J Immunol. 2004 Feb 15;172(4):2011-5.

15.

CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling.

Léveillé C, Bouillon M, Guo W, Bolduc J, Sharif-Askari E, El-Fakhry Y, Reyes-Moreno C, Lapointe R, Merhi Y, Wilkins JA, Mourad W.

J Biol Chem. 2007 Feb 23;282(8):5143-51. Epub 2006 Dec 19.

16.
17.

Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.

Menchén L, Marín-Jiménez I, Arias-Salgado EG, Fontela T, Hernández-Sampelayo P, Rodríguez MC, Butta NV.

Gut. 2009 Jul;58(7):920-8. doi: 10.1136/gut.2008.150318. Epub 2008 Nov 27.

PMID:
19039088
18.

Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients.

Fernández Bello I, Álvarez MT, López-Longo FJ, Arias-Salgado EG, Martín M, Jiménez-Yuste V, Rodríguez de la Rúa A, Butta NV.

Thromb Haemost. 2012 Jan;107(1):88-98. doi: 10.1160/TH11-08-0556. Epub 2011 Nov 24.

PMID:
22116092
19.
20.

P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.

Zhao L, Bath PM, May J, Lösche W, Heptinstall S.

Platelets. 2003 Nov-Dec;14(7-8):473-80. Erratum in: Platelets. 2004 Feb;15(1):63.

PMID:
14713516

Supplemental Content

Support Center